HIP-2101

N/A

Report date: 2025/08/19 13:50:31

Base Information

Drug NameHIP-2101
Drug Alias Namethe dual delayed-release formulation of 10-mg esomeprazoleHIP-2101
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGastritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A